ANDROGEN RECEPTOR INHIBITORS AND METHODS OF USE THEREOF
申请人:Rigby Alan C.
公开号:US20140088187A1
公开(公告)日:2014-03-27
The present invention relates to novel aryl sulfonamide compounds use of such compounds in the inhibition of androgen receptor and in the treatment of various diseases, disorders or conditions related to androgen receptor.
Cu‐Catalyzed Coupling Reactions of Sulfonamides with (Hetero)Aryl Chlorides/Bromides
作者:Qiaoli Li、Lanting Xu、Dawei Ma
DOI:10.1002/anie.202210483
日期:2022.10.24
of (hetero)aryl halides proceeds with excellent reaction scope by using oxalamides or 4-hydroxypicolinamides as the ligands. For bromides, only 2–5 mol % CuI and oxalamides were required. For chlorides, increasing catalytic loadings to 10 mol % Cu2O and ligands was needed. Direct sulfonamidation of four chloro-containing marketed drugs and preparation of two sulfonamide drugs were achieved under these
通过使用草酰胺或 4-羟基吡啶甲酰胺作为配体,Cu 催化的(杂)芳基卤化物磺酰胺化反应具有出色的反应范围。对于溴化物,仅需要 2–5 mol% CuI 和草酰胺。对于氯化物,需要将催化负载增加到 10 mol% Cu 2 O 和配体。在此条件下实现了四种含氯市售药物的直接磺酰胺化和两种磺胺类药物的制备。
[EN] ANDROGEN RECEPTOR INHIBITORS AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS DU RÉCEPTEUR DES ANDROGÈNES ET LEURS PROCÉDÉS D'UTILISATION
申请人:BETH ISRAEL HOSPITAL
公开号:WO2012082862A2
公开(公告)日:2012-06-21
The present invention relates to novel aryl sulfonamide compounds use of such compounds in the inhibition of angrogen receptor and in the treatment of various diseases, disorders or conditions related to androgen receptor.